Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology lead asset, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases.

• Revenue in CAD (TTM)0.00
• Net income in CAD-40.73m
• Incorporated2001
• Employees--

• Location
  Sernova Corp700 Collip Circle, Ste 114LONDON N6G 4X8CanadaCAN
• Phone+1 (519) 858-5126
• Fax+1 (519) 858-5126
• Websitehttps://www.sernova.com/